A non-interventional post-authorisation safety study (PASS) of vortioxetine in Europe

31/05/2017
23/10/2025
EU PAS number:
EUPAS19199
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

16034N Master Protocol v2.0 Abstract

English (247.76 KB - PDF) View document
Study results
Study report
Other information
Publications
Study publications
Vortioxetine in the routine management of major depressive disorder: an analysi…